logologo
QuantliQuantli

Arcturus Therapeutics Holdings Inc

ARCT

NASDAQ

Biotechnology

$8.23

USD

+0.37 (+4.71%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $222.41M

Volume 930.3K

Price Target

$27.00$27.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $27.00 and a min estimate of $27.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$27.00

+$8.0 vs prior

Implied Upside

+228.1%

+97.2% vs prior

Analyst Covering

1

-3 vs prior period

Consensus

Buy

Improved vs prior

Signal Quality

Consensus Freshness

20%

Many ratings are older - consensus may be less current

Analyst Agreement

High

Targets are closely clustered - analysts agree more than usual

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Ilya Zubkov

Freedom Capital Markets

Buy

Initiated

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

AKBA

Akebia Therapeutics Inc

$0.8700

+0.4%

GLSI

Greenwich Lifesciences Inc

$16.80

+2.6%

CNXU

Conexeu Sciences Inc

$8.90

+11.7%

TARA

Protara Therapeutics Inc

$3.97

+0.8%

ORGO

Organogenesis Holdings Inc

$1.79

+1.7%

ALEC

Alector Inc

$1.96

-3.9%

NBP

NovaBridge Biosciences

$1.96

+3.2%

RCEL

AVITA Medical Inc

$7.85

-2.0%

IMUX

Immunic Inc

$16.06

-3.1%